Literature DB >> 29540340

MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.

Manuela Germeshausen1, Phil Ancliff2, Jaime Estrada3, Markus Metzler4, Eva Ponstingl5, Horst Rütschle5, Dirk Schwabe6, Richard H Scott7, Sule Unal8, Angela Wawer9, Bernward Zeller10, Matthias Ballmaier1.   

Abstract

Heterozygous mutations in MECOM (MDS1 and EVI1 complex locus) have been reported to be causative of a rare association of congenital amegakaryocytic thrombocytopenia and radioulnar synostosis. Here we report on 12 patients with congenital hypomegakaryocytic thrombocytopenia caused by MECOM mutations (including 10 novel mutations). The mutations affected different functional domains of the EVI1 protein. The spectrum of phenotypes was much broader than initially reported for the first 3 patients; we found familial as well as sporadic cases, and the clinical spectrum ranged from isolated radioulnar synostosis with no or mild hematological involvement to severe bone marrow failure without obvious skeletal abnormality. The clinical picture included radioulnar synostosis, bone marrow failure, clinodactyly, cardiac and renal malformations, B-cell deficiency, and presenile hearing loss. No single clinical manifestation was detected in all patients affected by MECOM mutations. Radioulnar synostosis and B-cell deficiency were observed only in patients with mutations affecting a short region in the C-terminal zinc finger domain of EVI1. We propose the term MECOM-associated syndrome for this heterogeneous hereditary disease and inclusion of MECOM sequencing in the diagnostic workup of congenital bone marrow failure.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29540340      PMCID: PMC5873238          DOI: 10.1182/bloodadvances.2018016501

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  48 in total

1.  Age-matched reference values for B-lymphocyte subpopulations and CVID classifications in children.

Authors:  E J H Schatorjé; E F A Gemen; G J A Driessen; J Leuvenink; R W N M van Hout; M van der Burg; E de Vries
Journal:  Scand J Immunol       Date:  2011-11       Impact factor: 3.487

2.  Congenital radioulnar synostosis.

Authors:  B P Simmons; W W Southmayd; E J Riseborough
Journal:  J Hand Surg Am       Date:  1983-11       Impact factor: 2.230

3.  Evi1 is specifically expressed in the distal tubule and duct of the Xenopus pronephros and plays a role in its formation.

Authors:  Claude Van Campenhout; Massimo Nichane; Aline Antoniou; Hélène Pendeville; Odile J Bronchain; Jean-Christophe Marine; Andre Mazabraud; Marianne L Voz; Eric J Bellefroid
Journal:  Dev Biol       Date:  2006-03-30       Impact factor: 3.582

4.  Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.

Authors:  Satoshi Nishikawa; Shunya Arai; Yosuke Masamoto; Yuki Kagoya; Takashi Toya; Naoko Watanabe-Okochi; Mineo Kurokawa
Journal:  Blood       Date:  2014-10-08       Impact factor: 22.113

Review 5.  Nature, nurture, or chance: stochastic gene expression and its consequences.

Authors:  Arjun Raj; Alexander van Oudenaarden
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

6.  EVI1 induces myelodysplastic syndrome in mice.

Authors:  Silvia Buonamici; Donglan Li; Yiqing Chi; Rui Zhao; Xuerong Wang; Larry Brace; Hongyu Ni; Yogen Saunthararajah; Giuseppina Nucifora
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease.

Authors:  Manuela Germeshausen; Matthias Ballmaier; Karl Welte
Journal:  Hum Mutat       Date:  2006-03       Impact factor: 4.878

8.  Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity.

Authors:  Keisuke Kataoka; Tomohiko Sato; Akihide Yoshimi; Susumu Goyama; Takako Tsuruta; Hiroshi Kobayashi; Munetake Shimabe; Shunya Arai; Masahiro Nakagawa; Yoichi Imai; Keiki Kumano; Katsuyoshi Kumagai; Naoto Kubota; Takashi Kadowaki; Mineo Kurokawa
Journal:  J Exp Med       Date:  2011-11-14       Impact factor: 14.307

9.  Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development.

Authors:  A S Perkins; J A Mercer; N A Jenkins; N G Copeland
Journal:  Development       Date:  1991-02       Impact factor: 6.868

10.  Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification.

Authors:  Edouard Cornet; Hossein Mossafa; Karine Courel; Jean-François Lesesve; Xavier Troussard
Journal:  BMC Res Notes       Date:  2016-03-02
View more
  11 in total

Review 1.  Distinguishing constitutional from acquired bone marrow failure in the hematology clinic.

Authors:  Emma M Groarke; Neal S Young; Katherine R Calvo
Journal:  Best Pract Res Clin Haematol       Date:  2021-06-02       Impact factor: 3.670

2.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2022-06-24       Impact factor: 8.542

Review 3.  Genetics of inherited thrombocytopenias.

Authors:  Julia T Warren; Jorge Di Paola
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

Review 4.  Inherited Platelet Disorders: An Updated Overview.

Authors:  Verónica Palma-Barqueros; Nuria Revilla; Ana Sánchez; Ana Zamora Cánovas; Agustín Rodriguez-Alén; Ana Marín-Quílez; José Ramón González-Porras; Vicente Vicente; María Luisa Lozano; José María Bastida; José Rivera
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 5.  Overview of inherited bone marrow failure syndromes.

Authors:  Meerim Park
Journal:  Blood Res       Date:  2022-04-30

6.  Utility of platelet cross-matching in a case of neonatal alloimmune thrombocytopenia associated with a de novo MECOM variant.

Authors:  Suvro Sankha Datta; Sabita Basu; Niharendu Ghara; Pulak Kole; Priti Khemka
Journal:  Blood Res       Date:  2021-03-31

Review 7.  The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome.

Authors:  Elena Masselli; Giulia Pozzi; Cecilia Carubbi; Marco Vitale
Journal:  Cells       Date:  2021-09-29       Impact factor: 6.600

Review 8.  Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.

Authors:  Serine Avagyan; Akiko Shimamura
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

Review 9.  Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition.

Authors:  Juehua Gao; Yihua Chen; Madina Sukhanova
Journal:  Life (Basel)       Date:  2021-12-29

10.  CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients.

Authors:  Manuela Germeshausen; Matthias Ballmaier
Journal:  Haematologica       Date:  2021-09-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.